Pancreatic Cancer Research

ResearcherNIHR Nottingham Digestive Diseases Biomedical Research UnitActive in the last 2 years

Dhanny Gomez

Matched on ORCID iD 0000-0002-7584-3884; OpenAlex author ID A5051258492. Sources: OpenAlex.

Their work

Papers
8 (first author 0, last author 2)
Trials
0
Grants
0
Labs led
0
Collaborators
48
Papers, trials and grants by year

2016: 1 paper · 2017: none · 2018: none · 2019: none · 2020: 1 paper · 2021: 1 paper · 2022: none · 2023: 1 paper · 2024: 1 paper · 2025: 3 papers

Papers 8

  1. Patterns, timing and predictors of recurrence following pancreaticoduodenectomy for pancreatic ductal adenocarcinoma: an international multicentre retrospectiv… Co-author DOI 10.1016/j.hpb.2024.11.015↗
  2. Long-term Outcomes Following Resection of Adenocarcinoma Arising from Intraductal Papillary Mucinous Neoplasm (A-IPMN) Versus Pancreatic Ductal Adenocarcinoma … Co-author DOI 10.1097/sla.0000000000006272↗
  3. Venous Resection During Pancreatoduodenectomy for Pancreatic Ductal Adenocarcinoma-A Multicentre Propensity Score Matching Analysis of the Recurrence After Whi… Co-author DOI 10.3390/cancers17071223↗
  4. Five-year recurrence/survival after pancreatoduodenectomy for pancreatic adenocarcinoma: does pre-existing diabetes matter? Results from the Recurrence After W… Co-author DOI 10.1016/j.hpb.2024.04.010↗
  5. Does an extensive diagnostic workup for upfront resectable pancreatic cancer result in a delay which affects survival? Results from an international multicentr… Co-author DOI 10.14701/ahbps.23-042↗
  6. Laparoscopic versus open extended radical left pancreatectomy for pancreatic ductal adenocarcinoma: an international propensity-score matched study. Co-author DOI 10.1007/s00464-020-08206-y↗
  7. Statin therapy does not influence the outcome of patients undergoing surgery for pancreatic cancer. Last author DOI 10.1111/ans.15600↗
  8. Indications for staging laparoscopy in pancreatic cancer. Last author DOI 10.1016/j.hpb.2015.10.004↗

Closest collaborators

The 25 strongest of 48 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Duncan R.C. Spalding · 2 shared papers, 2023–2025 · strength 0.28
  2. Alberto Porcu · 2 shared papers, 2023–2025 · strength 0.28
  3. Thomas Brendon Russell · 2 shared papers, 2023–2025 · strength 0.28
  4. Fabio Ausania · 2 shared papers, 2023–2025 · strength 0.28
  5. Ricky Harminder Bhogal · 2 shared papers, 2023–2025 · strength 0.28
  6. Somaiah Aroori · 2 shared papers, 2023–2025 · strength 0.28
  7. Ismael Domínguez-Rosado · 2 shared papers, 2023–2025 · strength 0.28
  8. Brian Ritchie Davidson · 2 shared papers, 2023–2025 · strength 0.28
  9. Manuel Maglione · 2 shared papers, 2023–2025 · strength 0.28
  10. Keith John Roberts · 2 shared papers, 2023–2025 · strength 0.28
  11. Peter Lawrence Zaki Labib · 2 shared papers, 2023–2025 · strength 0.28
  12. Andrew Malvern Smith · 2 shared papers, 2023–2025 · strength 0.28
  13. Zaed Z. R. Hamady · 2 shared papers, 2023–2025 · strength 0.28
  14. Daniel Gerald Croagh · 2 shared papers, 2023–2025 · strength 0.28
  15. Elizabeth Pando · 2 shared papers, 2023–2025 · strength 0.28
  16. Adam Enver Frampton · 2 shared papers, 2023–2025 · strength 0.28
  17. Bilal A. Al-Sarireh · 2 shared papers, 2021–2025 · strength 0.25
  18. Ruben Bellotti · 1 shared paper, 2025 · strength 0.16
  19. Dimitrios D. Karavias · 1 shared paper, 2020 · strength 0.13
  20. Ashray Rajagopalan · 1 shared paper, 2023 · strength 0.12
  21. Antonella De Rosa · 1 shared paper, 2016 · strength 0.10
  22. Alberto Balduzzi · 1 shared paper, 2021 · strength 0.08
  23. Tobias Keck · 1 shared paper, 2021 · strength 0.08
  24. Riccardo Casadei · 1 shared paper, 2021 · strength 0.08
  25. Andrea Pietrabissa · 1 shared paper, 2021 · strength 0.08

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.